Skip to main content
Launch offer40% off your first paymentEnds 31 DecemberSee plans
Mineralys Therapeutics logo

Mineralys Therapeutics

Biotech & Pharmaceuticals
WebsiteLinkedIn

We are deeply focused on how to address cardio-renal-metabolic syndrome (CRMS) diseases, particularly for people with dysregulated aldosterone, with the initial treatment target being hypertension.

Open roles
4
Company size
1 - 50 employees
Headquarters
Radnor, Pennsylvania, United States
Founded
2019

Follow Mineralys Therapeutics

Create an exact-company alert for on-site matches and optional daily email.

Open roles

Launch offer: 40% off1 more roles at Mineralys Therapeutics
You see 3 of 4 on this board. A plan shows every role at every company, from $12 a week. Already have a plan? Log in
Already have a plan? Log in